Birgit Tockner
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: March 28, 2023
Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer.
Journal: International journal of molecular sciences
Published: October 28, 2021
Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: September 24, 2021
Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial.
Journal: Orphanet journal of rare diseases
Published: May 17, 2021
Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction.
Journal: Cells
Published: December 31, 2019
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
Journal: Scientific reports
Published: November 27, 2017
The effect of vasopressin on ciliary blood flow and aqueous flow.
Journal: Investigative ophthalmology & visual science
Published: December 12, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026